Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v2.4.1.9
Segment Reporting
 6 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
13.
Segment Reporting
 
As discussed above, iBio Brazil began operations in the first quarter of fiscal 2015. In accordance with FASB ASC 280, “Segment Reporting,” the Company discloses financial and descriptive information about its reportable geographic segments. Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.
 
 
 
 
 
iBio
 
 
 
Three months ended December 31, 2014
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
367
 
$
-
 
$
367
 
Research and development expenses
 
 
731
 
 
-
 
 
731
 
General and administrative expenses
 
 
1,272
 
 
30
 
 
1,302
 
Operating loss
 
 
(1,636)
 
 
(30)
 
 
(1,666)
 
 
 
 
 
 
iBio
 
 
 
Six months ended December 31, 2014
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
1,186
 
$
-
 
$
1,186
 
Research and development expenses
 
 
1,916
 
 
-
 
 
1,916
 
General and administrative expenses
 
 
2,301
 
 
51
 
 
2,352
 
Operating loss
 
 
(3,031)
 
 
(51)
 
 
(3,082)
 
Total assets
 
 
10,939
 
 
103
 
 
11,042